Inventor
GREGORY R. THATCHER
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes26%
C07BGeneral methods of organic chemistry9%
PatentTitleYear
12,552,760Compounds for increasing the nicotinamide adenine dinucleotide in a subject and methods of use thereof202612,295,939Substituted benzothiophene analogs as selective estrogen receptor degraders202512,054,469Benzothiophene-based selective estrogen receptor downregulator compounds202411,840,533Pyridinone-based epigenetic modifiers and uses thereof202311,787,769Inhibitors of influenza viral entry202311,759,450Substituted benzothiophene analogs as selective estrogen receptor degraders202311,447,461Benzothiophene-based selective estrogen receptor downregulators202211,364,222Combination therapy for treatment of cancer202211,332,466Pyridinone-based epigenetic modifiers and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to UNIV ILLINOIS (9)· patent assignee history
2022Patents assigned to G1 THERAPEUTICS INC (1)· patent assignee history
2022–2026Based in US· patent location history
2023Patents assigned to CHICAGO BIOSOLUTIONS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV ILLINOIS | 9 | 2022–2026 |
| CHICAGO BIOSOLUTIONS INC | 1 | 2023 |
| G1 THERAPEUTICS INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2022–2026 |